Cargando…
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial
SIMPLE SUMMARY: Women with disease-causing gene changes (faults/mutations) in BRCA1, BRCA2, PALB2, CHEK2 and ATM are at an increased risk of developing certain types of cancer—specifically breast (all genes) and epithelial ovarian cancer (only BRCA1, BRCA2, PALB2). At present, the risk estimates giv...
Autores principales: | Archer, Stephanie, Fennell, Nichola, Colvin, Ellen, Laquindanum, Rozelle, Mills, Meredith, Dennis, Romy, Stutzin Donoso, Francisca, Gold, Rochelle, Fan, Alice, Downes, Kate, Ford, James, Antoniou, Antonis C., Kurian, Allison W., Evans, D. Gareth, Tischkowitz, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179465/ https://www.ncbi.nlm.nih.gov/pubmed/35681696 http://dx.doi.org/10.3390/cancers14112716 |
Ejemplares similares
-
Exploring the barriers to and facilitators of implementing CanRisk in primary care: a qualitative thematic framework analysis
por: Archer, Stephanie, et al.
Publicado: (2023) -
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening
por: Usher-Smith, Juliet A., et al.
Publicado: (2023) -
BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis
por: Nyberg, Tommy, et al.
Publicado: (2021) -
Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancer
por: Fennell, Dean A, et al.
Publicado: (2012) -
Personalised analytics for rare disease diagnostics
por: Anderson, Denise, et al.
Publicado: (2019)